These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 35101110

  • 1. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL, Bunce C, Desai R, Hillenkamp J, Lee CN, Lois N, Peto T, Reeves BC, Steel DH, Edwards RT, van Meurs JC, Wafa H, Wang Y.
    Trials; 2022 Jan 31; 23(1):99. PubMed ID: 35101110
    [Abstract] [Full Text] [Related]

  • 2. Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.
    Gabrielle PH, Delyfer MN, Glacet-Bernard A, Conart JB, Uzzan J, Kodjikian L, Arndt C, Tadayoni R, Soudry-Faure A, Creuzot Garcher CP.
    Ophthalmology; 2023 Sep 31; 130(9):947-957. PubMed ID: 37088447
    [Abstract] [Full Text] [Related]

  • 3. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec 31; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 4. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 31; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 5. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Jun 31; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun 31; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May 31; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Kim JH, Kim CG, Lee DW, Yoo SJ, Lew YJ, Cho HJ, Kim JY, Lee SH, Kim JW.
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan 31; 258(1):107-116. PubMed ID: 31741044
    [Abstract] [Full Text] [Related]

  • 9. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA, Nawrocki J.
    Ophthalmologica; 2024 Jan 31; 247(1):58-64. PubMed ID: 38113868
    [Abstract] [Full Text] [Related]

  • 10. Naïve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study.
    Iglicki M, Khoury M, Melamud JI, Donato L, Barak A, Quispe DJ, Zur D, Loewenstein A.
    Eye (Lond); 2023 Jun 31; 37(8):1659-1664. PubMed ID: 36038720
    [Abstract] [Full Text] [Related]

  • 11. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy.
    Matsunaga DR, Su D, Sioufi K, Obeid A, Wibbelsman T, Ho AC, Regillo CD.
    Ophthalmol Retina; 2021 Apr 31; 5(4):342-347. PubMed ID: 32763426
    [Abstract] [Full Text] [Related]

  • 12. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT, Lai JC, Wee R, Yanagihara R, Shantha JG, Ayabe J, Hirai K.
    BMC Ophthalmol; 2016 Jul 27; 16():127. PubMed ID: 27465105
    [Abstract] [Full Text] [Related]

  • 13. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L, Saad AAA, Vaideanu-Collins D, Isac M, Hamada D, El-Haig WM.
    Eur J Ophthalmol; 2021 Sep 27; 31(5):2621-2624. PubMed ID: 32993349
    [Abstract] [Full Text] [Related]

  • 14. The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration.
    Shin KH, Lee TG, Kim JH, Kim JW, Kim CG, Lee DW, Han JI, Lew YJ, Cho HJ.
    Korean J Ophthalmol; 2016 Oct 27; 30(5):369-376. PubMed ID: 27729757
    [Abstract] [Full Text] [Related]

  • 15. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun 27; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 16. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature.
    Stanescu-Segall D, Balta F, Jackson TL.
    Surv Ophthalmol; 2016 Jun 27; 61(1):18-32. PubMed ID: 26212151
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial.
    Jackson TL, Soare C, Petrarca C, Simpson A, Neffendorf JE, Petrarca R, Muldrew A, Peto T, Chakravarthy U, Membrey L, Haynes R, Costen M, Steel D, Desai R, MERLOT Study Group.
    JAMA Ophthalmol; 2020 Aug 01; 138(8):835-842. PubMed ID: 32644148
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Aug 01; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 19. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
    Caporossi T, Bacherini D, Governatori L, Oliverio L, Di Leo L, Tartaro R, Rizzo S.
    Acta Ophthalmol; 2022 Aug 01; 100(5):e1143-e1152. PubMed ID: 34609787
    [Abstract] [Full Text] [Related]

  • 20. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct 01; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.